English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Hepatitis B virus (HBV) reactivation (HBVr) in patients receiving immunosuppression is an evolving topic. Terminology of HBV status include active carrier (AC) who are HbsAg positive with elevated HBVDNA (>2000IU/mL), occult HBV carrier (OBI) who are HbsAg negative but Anti HBc positive with absent HBVDNA and positive or negative AntiHBs, inactive carrier (IC) HbsAg positive but HBVDNA is absent or <2000IU/mL (1).

easterns journal of medicine/eastern journal of medicine

Reactivation of Hepatitis B Virus Infection 66 months after Rituximab Therapy For Chronic Lymphocytic Leukemia, Emphasis on Interplay between Infection, Drugs and Disease Biology